Sign In
12 Aug 2014 16:32
GW Pharmaceuticals PLC Director/PDMR Shareholding
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company", "GW")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 12 August 2014: GW Pharmaceuticals (NASDAQ: GWPH, AIM: GWP) hereby provides notification that the Company has today granted the following awards to Directors over the Company's Ordinary shares ("Shares") in the form of nominal-cost options ("Awards") under the GW Pharmaceuticals plc Long-Term Incentive Plan, which was approved by shareholders on 18 March 2008:
Name |
Number of Ordinary Shares under this Award |
Total number of Ordinary Shares over which options / awards held |
Dr Geoffrey Guy | 82,639 | 1,997,352 |
Justin Gover | 67,955 | 1,695,833 |
Dr Stephen Wright | 56,735 | 1,168,446 |
Chris Tovey | 50,018 | 516,575 |
Adam George | 46,071 | 563,993 |
The Remuneration Committee consider that retention of the Executive Director team is likely to be a key success factor that will contribute towards the successful execution of the Company's strategy. Vesting of these Awards is therefore linked to a service condition requiring 3 years' service by each Director. Subject to successful completion of this service period the Awards will vest and become exercisable upon the third anniversary of the date of grant.
Once vested, an Award may be exercised at any time prior to the tenth anniversary of the date of grant. The exercise price of the Awards is 0.1p per Share, being the par value of the Shares. Awards which do not vest on 12 August 2017 will lapse permanently.
Enquiries:
GW Pharmaceuticals PLC
Adam George, CFO/Company Secretary Tel: +44 (0)1980 557 000
Stephen Shultz, VP Investor Relations Tel: 917 280 2424
Peel Hunt LLP (Nominated Adviser) Tel: +44 (0)207 418 8900
James Steel/Oliver Jackson
Follow the stocks
